proposed compounds of formula (i) or their \u0444\u0430\u0440\u043c\u0430\u0446\u0435\u0432\u0442\u0438\u0447\u0435\u0441\u043a\u0438 suitable salts, where r1 represents a group selected from: (i) a phenyl, optionally \u0437\u0430\u043c\u0435\u0449\u0435\u043d\u043d\u043e\u0433\u043e one or two vice, independently selected from me, OMe, cf3, f, cl, and NMe2 (ii) \u0444\u0443\u0440\u0430\u043d\u0438\u043b\u0430, \u0442\u0438\u043e\u0444\u0435\u043d\u0438\u043b\u0430, \u043f\u0438\u0440\u0440\u043e\u043b\u0438\u043b\u0430, \u043f\u0438\u0440\u0438\u0434\u0438\u043b\u0430, \u0446\u0438\u043a\u043b\u043e\u0433\u0435\u043a\u0441\u0438\u043b\u0430 or \u043d\u0430\u0444\u0442\u0438\u043b\u0430, each of which \u043d\u0435\u043e\u0431\u044f\u0437\u0430\u0442 \u0435\u043b\u044c\u043d\u043e replaced one or two deputiesindependently selected from me, OMe, cf3, f, cl, and NMe2 and (iii) benzo [1,3] - 5 - \u0434\u0438\u043e\u043a\u0441\u043e slime or 2.3 \u0434\u0438\u0433\u0438\u0434\u0440\u043e\u0431\u0435\u043d\u0437\u043e [1.4] dioxin - 6 - silt r2 is cf3, c1 - 4\u0430\u043b\u043a\u0438\u043b or CHF2 if r1 is wallpaper is not necessarily \u0437\u0430\u043c\u0435\u0449\u0435\u043d\u043d\u044b\u0439 \u0444\u0443\u0440\u0430\u043d\u0438\u043b, \u0442\u0438\u043e\u0444\u0435\u043d\u0438\u043b, \u043f\u0438\u0440\u0440\u043e\u043b\u0438\u043b, \u043f\u0438\u0440\u0438\u0434\u0438\u043b or \u043d\u0430\u0444\u0442\u0438\u043b, r3 represents a et when r1 represents optionally \u0437\u0430\u043c\u0435\u0449\u0435\u043d\u043d\u044b\u0439 \u0446\u0438\u043a\u043b\u043e\u0433\u0435 \u043a\u0441\u0438\u043b,r3 represents a et or me in other cases, r3 represents a et, me, br or OMe compositions containing them, their use in therapy, for example, for the treatment of tuba \u0440\u043a\u0443\u043b\u0435\u0437\u0430, and ways of obtaining such compounds, along with some of the new compounds.Предложены соединения формулы (I) или их фармацевтически приемлемые соли, где R1 представляет собой гр
